These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3122245)

  • 21. Different effects of muscarinic agonists in rat superior cervical ganglion and hippocampal slices.
    Boddeke HW
    Eur J Pharmacol; 1991 Aug; 201(2-3):191-7. PubMed ID: 1724649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central pressor effects induced by muscarinic receptor agonists: evidence for a predominant role of the M2 receptor subtype.
    Pazos A; Wiederhold KH; Palacios JM
    Eur J Pharmacol; 1986 Jun; 125(1):63-70. PubMed ID: 3732392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of some cholinergic agonists on neocortical slow wave activity in rats with basal forebrain lesions.
    Vanderwolf CH; Raithby A; Snider M; Cristi C; Tanner C
    Brain Res Bull; 1993; 31(5):515-21. PubMed ID: 8495376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dorsolateral frontal cortex and peripheral muscarinic receptors participation in the discriminative stimulus properties of scopolamine in rats.
    Aguayo-DelCastillo A; Vélazquez-Martínez DN; Sánchez-Castillo H; Casasola C
    Pharmacol Biochem Behav; 2013 Aug; 109():44-9. PubMed ID: 23664898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scopolamine self-administration: cholinergic involvement in reward mechanisms.
    Glick SD; Guido RA
    Life Sci; 1982 Aug; 31(9):909-13. PubMed ID: 7176819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigations on the CNS sites of action of the discriminative stimulus effects of arecoline and nicotine.
    Meltzer LT; Rosecrans JA
    Pharmacol Biochem Behav; 1981 Jul; 15(1):21-6. PubMed ID: 7291225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rhythmical slow wave electroencephalographic activity elicited by hippocampal injection of muscarinic agents in the rat.
    Malisch R; Ott T
    Neurosci Lett; 1982 Jan; 28(1):113-8. PubMed ID: 7063141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in rats.
    Shannon HE; Hart JC; Bymaster FP; Calligaro DO; DeLapp NW; Mitch CH; Ward JS; Fink-Jensen A; Sauerberg P; Jeppesen L; Sheardown MJ; Swedberg MD
    J Pharmacol Exp Ther; 1999 Aug; 290(2):901-7. PubMed ID: 10411607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of the muscarinic receptor subtype involved in the mediation of pilocarpine-induced purposeless chewing behaviour.
    Stewart BR; Jenner P; Marsden CD
    Psychopharmacology (Berl); 1989; 97(2):228-34. PubMed ID: 2498932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of scopolamine, pilocarpine, and oxotremorine on the exploratory behavior of two psychogenetically selected lines of rats in a complex maze.
    Martin JR; Overstreet DH; Driscoll P; Bättig K
    Psychopharmacology (Berl); 1981; 72(2):135-42. PubMed ID: 6782602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of cholinergic drugs on discriminative cues and self-stimulation produced by electrical stimulation of the ventral tegmental area.
    Druhan JP; Fibiger HC; Phillips AG
    Psychopharmacology (Berl); 1989; 97(3):331-8. PubMed ID: 2497481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions of agonists with M2 and M4 muscarinic receptor subtypes mediating cyclic AMP inhibition.
    McKinney M; Miller JH; Gibson VA; Nickelson L; Aksoy S
    Mol Pharmacol; 1991 Dec; 40(6):1014-22. PubMed ID: 1722002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A centrally mediated prolonged hypotension produced by oxotremorine or pilocarpine.
    Dage RC
    Br J Pharmacol; 1979 Jan; 65(1):15-21. PubMed ID: 760887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of training dose on discrimination and cross-generalization of chlordiazepoxide, pentobarbital and ethanol in the rat.
    De Vry J; Slangen JL
    Psychopharmacology (Berl); 1986; 88(3):341-5. PubMed ID: 3083454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonmuscarinic neurotoxicity of oxotremorine.
    Witkin JM; Alvarado-Garcia R; Lee MA; Witkin KM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):34-41. PubMed ID: 3572794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of muscarinic receptor agonists and antagonists on alpha 2-adrenoceptors in rat brain.
    Hollingsworth PJ; Smith CB
    Eur J Pharmacol; 1989 Sep; 168(2):159-67. PubMed ID: 2558024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct measurement of muscarinic agents in the central nervous system of mice using ex vivo binding.
    Freedman SB; Harley EA; Patel S
    Eur J Pharmacol; 1989 Dec; 174(2-3):253-60. PubMed ID: 2630302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats.
    See RE; Chapman MA
    Pharmacol Biochem Behav; 1991 May; 39(1):49-54. PubMed ID: 1924511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoradiographic analyses of agonist binding to muscarinic receptor subtypes.
    Messer WS; Ellerbrock B; Price M; Hoss W
    Biochem Pharmacol; 1989 Mar; 38(5):837-50. PubMed ID: 2564779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of muscarinic ligands on the electrical activity recorded from the hippocampus: a quantitative approach.
    Bevan P
    Br J Pharmacol; 1984 Jun; 82(2):431-40. PubMed ID: 6375796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.